By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:



ACADIA Pharmaceuticals, Inc.  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist Pharmaceuticals, Inc. 

Company News
Sunovion Pharmaceuticals Inc. Release: Investigational Drug Dasotraline Significantly Improved Symptoms Of Attention Deficit Hyperactivity Disorder (ADHD) In A Placebo-Controlled Study In Adults 12/11/2014 8:14:35 AM
Sunovion Pharmaceuticals Inc. Submits Supplemental New Drug Application Seeking Approval For The Use Of Aptiom® (Eslicarbazepine Acetate) As Monotherapy Treatment For Partial-Onset Seizures 12/5/2014 9:08:25 AM
Sunovion Pharmaceuticals Inc. And The COPD Foundation Expand COPD Together Campaign To Empower Family Caregivers 11/5/2014 10:43:47 AM
ex scientia Ltd. Partners With Sunovion Pharmaceuticals Inc. To Research New Medicines For Psychiatric Disorders 11/4/2014 10:30:31 AM
CHEST, Sunovion Pharmaceuticals Inc. Encourage COPD Education Among Hispanics During COPD Awareness Month 11/3/2014 9:23:55 AM
Sunovion Pharmaceuticals Inc. Announces Dose Ranging Data From Phase 2 Study Of SUN-101 (Glycopyrrolate) Inhalation Solution For Treatment Of Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease (COPD) 10/27/2014 3:04:46 PM
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution 10/1/2014 5:53:07 AM
Sunovion Pharmaceuticals Inc. Announces Data Published In The CHEST Journal From A One-Year, Large Simple Safety Study Evaluating BROVANA® (Arformoterol Tartrate) Inhalation Solution 7/8/2014 7:21:21 AM
FDA Slashes Starting Dose For Sunovion Pharmaceuticals Inc.'s Lunesta; Warns Risk Of Next-Day Impairment 5/15/2014 3:17:45 PM
Sunovion Pharmaceuticals Inc. Release: Once-Daily Aptiom® (Eslicarbazepine Acetate) For The Adjunctive Treatment Of Partial-Onset Seizures Now Available In U.S. Pharmacies 4/7/2014 10:15:05 AM